Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study

David C. Wheeler, Bertram L. Kasiske

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

The clinical benefits of statins in dialysis patients are unproven. New follow-up data from the 4D Study indicate no clear reduction in cardiovascular events among patients with type-2 diabetes. Assessing outcomes 7.4 years beyond the randomization period (20 mg atorvastatin versus placebo), no differences in a composite cardiovascular outcome were observed and no safety concerns emerged. Current Kidney Disease: Improving Global Outcomes (KDIGO) guidelines do not need updating based on these new data.

Original languageEnglish (US)
Pages (from-to)1189-1191
Number of pages3
JournalKidney international
Volume89
Issue number6
DOIs
StatePublished - 2016

Fingerprint Dive into the research topics of 'Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study'. Together they form a unique fingerprint.

  • Cite this